Mutations causing DOK7 congenital myasthenia ablate functional motifs in Dok-7.
Dok-7 is a cytoplasmic activator of muscle-specific receptor-tyrosine kinase (MuSK). Both Dok-7 and MuSK are required for neuromuscular synaptogenesis. Mutations in DOK7 underlie a congenital myasthenic syndrome (CMS) associated with small and simplified neuromuscular synapses likely due to impaired...
Κύριοι συγγραφείς: | Hamuro, J, Higuchi, O, Okada, K, Ueno, M, Iemura, S, Natsume, T, Spearman, H, Beeson, D, Yamanashi, Y |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
2008
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Dose escalation pre-clinical trial of novel DOK7-AAV in mouse model of DOK7 congenital myasthenia
ανά: Cossins, J, κ.ά.
Έκδοση: (2025) -
Congenital myasthenia: contrasting rapsyn and Dok-7 phenotypes
ανά: Palace, J
Έκδοση: (2010) -
Dok-7/MuSK signaling and a congenital myasthenic syndrome.
ανά: Yamanashi, Y, κ.ά.
Έκδοση: (2008) -
EPHEDRINE TREATMENT RESULTS IN PROFOUND FUNCTIONAL IMPROVEMENTS IN DOK-7 CONGENITAL MYASTHENIA
ανά: Lashley, D, κ.ά.
Έκδοση: (2009) -
Dok-7 mutations underlie a neuromuscular junction synaptopathy.
ανά: Beeson, D, κ.ά.
Έκδοση: (2006)